Innoviva, Inc. (NASDAQ: INVA)
$17.2400
-0.0700 ( +0.64% ) 122.5K
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Market Data
Open
$17.2400
Previous close
$17.3100
Volume
122.5K
Market cap
$1.07B
Day range
$17.0510 - $17.2950
52 week range
$14.3250 - $21.2800
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Jun 20, 2024 |
| 8-k | 8K-related | 13 | Jun 20, 2024 |
| 4 | Insider transactions | 1 | Jun 20, 2024 |
| 4 | Insider transactions | 1 | May 21, 2024 |
| 4 | Insider transactions | 1 | May 21, 2024 |
| 8-k | 8K-related | 42 | May 13, 2024 |
| ars | Annual reports | 1 | May 09, 2024 |
| 8-k | 8K-related | 15 | May 08, 2024 |
| 10-q | Quarterly Reports | 81 | May 08, 2024 |
| 3 | Insider transactions | 1 | May 01, 2024 |